Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (101) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter CMDh final position Remove CMDh final position filter Under evaluation (1) Apply Under evaluation filter

Referral safety status

Yes (8) Apply Yes filter

Referral type

Article 30 referrals Remove Article 30 referrals filter Article 107i procedures Remove Article 107i procedures filter Article 29(4) referrals (116) Apply Article 29(4) referrals filter Article 31 referrals (113) Apply Article 31 referrals filter Article 33 (43) Apply Article 33 filter Article 35 (40) Apply Article 35 filter Article 20 procedures (22) Apply Article 20 procedures filter Article 6(12) referrals (prior to January 2010) (21) Apply Article 6(12) referrals (prior to January 2010) filter Article 34 (18) Apply Article 34 filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 13 (6) Apply Article 13 filter Article 13 referrals (6) Apply Article 13 referrals filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 78 (5) Apply Article 78 filter Articles 39 and 40 (4) Apply Articles 39 and 40 filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter

Referral reference number

Referral decision making model

PRAC-CMDh (8) Apply PRAC-CMDh filter

Referral authorisation model

Nationally authorised product(s) (9) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (4) Apply Risk minimisation measures filter Suspension (3) Apply Suspension filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Related medicine

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

101 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Referral type Article 107i procedures Remove Article 107i procedures filter Article 30 referrals Remove Article 30 referrals filter

Referral status CMDh final position Remove CMDh final position filter European Commission final decision Remove European Commission final decision filter

Sort by

List item

Referral: Fenspiride containing medicinal products

fenspiride, Article 107i procedures
Status: CMDh final position, opinion/position date: 29/05/2019, Last updated: 26/06/2019
List item

Referral: Septanest and associated names

articaine (hydrochloride) / adrenaline (tartrate), Article 30 referrals
Status: European Commission final decision, opinion/position date: 28/06/2018, EC decision date: 28/03/2019, Last updated: 19/06/2019
List item

Referral: Scandonest and associated names

mepivacaine, associated names: Biocaine, Scandicaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 31/05/2018, EC decision date: 02/08/2018, Last updated: 07/08/2018
List item

Referral: Hydroxyethyl starch (HES) containing medicinal products

hydroxyethyl starch (HES), Article 107i procedures
Status: European Commission final decision, opinion/position date: 26/10/2017, EC decision date: 17/07/2018, Last updated: 27/07/2018
List item

Referral: Vepesid

etoposide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2017, EC decision date: 26/06/2017, Last updated: 14/07/2017
List item

Referral: Etopophos

etoposide phosphate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2017, EC decision date: 26/06/2017, Last updated: 14/07/2017
List item

Referral: Saroten and associated names

amitriptyline, associated names: Saroten Retard, Redomex, Redomex Diffucaps, Saroten Tabs, Saroten retard Tabs, Saroten 2ml, Sarotex, Sarotex Retard, Sarotex Retard 25, Sarotex Retard 50, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 08/05/2017, Last updated: 06/06/2017
List item

Referral: Haldol Decanoate and associated names

haloperidol decanoate, associated names: Haldol Decanoat, Haldol Decanoas, Serenase Dekanoat, Serenase Depot, Haldol - Janssen Decanoat Depot, Haldol Decanoato, Haldol Depot, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 11/05/2017
List item

Referral: Haldol and associated names

haloperidol, associated names: Aloperidin, Haldol-Janssen, Serenase, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 05/05/2017
List item

Referral: Lovenox and associated names

enoxaparin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/12/2016, EC decision date: 09/03/2017, Last updated: 22/03/2017
List item

Referral: Clenil and associated names

beclometasone dipropionate, associated names: Becloneb, Beclospin and Sanasthmax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/09/2016, EC decision date: 11/11/2016, Last updated: 18/11/2016
List item

Referral: Durogesic and associated names

fentanyl, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 22/09/2016, Last updated: 19/10/2016
List item

Referral: Novantrone and associated names

mitoxantrone, associated names: Elsep, Ralenova, Article 30 referrals
Status: European Commission final decision, opinion/position date: 28/04/2016, EC decision date: 24/06/2016, Last updated: 05/07/2016
List item

Referral: Cymevene

ganciclovir, associated names: Cymevan, Citovirax, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 28/04/2016, Last updated: 21/06/2016
List item

Referral: Amoxil

amoxicillin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/06/2015, EC decision date: 20/08/2015, Last updated: 19/05/2016
List item

Referral: Ikorel and Dancor

nicorandil, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/03/2015, EC decision date: 05/06/2015, Last updated: 30/06/2015
List item

Referral: Plendil and associated names

felodipine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 16/12/2014, Last updated: 30/03/2015
List item

Referral: Nasonex

mometasone furoate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 19/01/2015, Last updated: 03/02/2015
List item

Referral: EMLA cream and associated names

lidocaine / prilocaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/09/2014, EC decision date: 28/11/2014, Last updated: 15/01/2015
List item

Referral: Seroquel / Seroquel XR and associated names

quetiapine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 06/08/2014, Last updated: 09/09/2014
List item

Referral: Methadone medicinal products for oral use containing povidone

methadone, Article 107i procedures
Status: CMDh final position, opinion/position date: 23/07/2014, Last updated: 04/08/2014
List item

Referral: Sandostatin and associated names

octreotide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2014, EC decision date: 26/06/2014, Last updated: 27/06/2014
List item

Referral: Sandostatin LAR and associated names

octreotide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2014, EC decision date: 26/06/2014, Last updated: 27/06/2014
List item

Referral: Rocephin

ceftriaxone, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/01/2014, EC decision date: 21/03/2014, Last updated: 19/05/2014
List item

Referral: Valtrex

valaciclovir, associated names: Zelitrex, Talavir, Valaciclovir Allen, Valherpes, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 13/07/2010, Last updated: 25/03/2014

Load more

101 results

Referral: Fenspiride containing medicinal products

Referral: Septanest and associated names

Referral: Scandonest and associated names

Referral: Hydroxyethyl starch (HES) containing medicinal products

Referral: Vepesid

Referral: Etopophos

Referral: Saroten and associated names

Referral: Haldol Decanoate and associated names

Referral: Haldol and associated names

Referral: Lovenox and associated names

Referral: Clenil and associated names

Referral: Durogesic and associated names

Referral: Novantrone and associated names

Referral: Cymevene

Referral: Amoxil

Referral: Ikorel and Dancor

Referral: Plendil and associated names

Referral: Nasonex

Referral: EMLA cream and associated names

Referral: Seroquel / Seroquel XR and associated names

Referral: Methadone medicinal products for oral use containing povidone

Referral: Sandostatin and associated names

Referral: Sandostatin LAR and associated names

Referral: Rocephin

Referral: Valtrex